Anda di halaman 1dari 6

DAFTAR PUSTAKA

1.

Guttmatcher Institute. Aborsi di Indonesia. Guttmatcher Institue. 2008

2.

Prawirohardjo, Sarwono. Ilmu Kebidanan.P.T Bina Pustaka Sarwono Prawirohardjo.2009

3.

Norman F. Gant MD, Kenneth J., Md Leveno, Larry C., Iii, Md Gilstrap, John C., MdHauth, Katharine
D., Md Wenstrom, John C.Hauth, J. Whitridge Obstetrics Williams(Editor), StevenL. Clark, Katharine
D. Wenstrom.Williams Obstetrics 23rd Ed: McGraw-Hill Professional

4.

McBride, Dorothy E. Abortion in United State. ABC-CLIO.2008

5.

Evans, Arthur T.Manual of Obstetric 7th ed .Lippincot Williams and Willkins. 2007

6.

Morgan, Mark. Siddighi, Sam.Obstetrics and Gynecology Volume 1.LippincotWilliams and Willkins.
2004

7.

R. James. Scoot, Md. S. Ronald et al.Danforths Obstetric and Gynecology 9thEdition.Lippincott


Williams & Wilkins. 2003

8.

Keeling, Jean W. Khong T Yee.Fetal and Neonatal Pathology. Springer. 2007

9.

World Health Organization. Safe Abortion: Technical and Policy Guidance for HealthSystems. World
Health Organization. 2003

10. Hatcher, Robert A. Trussell, James.Nelson, Anita L. Contraceptice Technology.Ardent Media. 2008
11. Aryanti, C., et al., Laporan Kasus Abortus Inkomplit. USU. 2013
http://www.ijgo.org/article/S0020-7292(12)00388-8/pdf
http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(14)61935-8.pdf
http://www.aafp.org/afp/2011/0201/p258.pdf
http://ac.els-cdn.com/S1110569013000794/1-s2.0-S1110569013000794main.pdf?_tid=71c614f2-5c8c-11e5-9ec000000aab0f6c&acdnat=1442419577_bdf1f258a04c6d27a11c8a8ccefe99f7
http://apps.who.int/rhl/pregnancy_childbirth/antenatal_care/miscarriage/ekcom/en
/#
http://www.acog.org/-/media/Committee-Opinions/Committee-on-InternationalAffairs/co427.pdf?dmc=1&ts=20150916T1206053964

DAFTAR PUSTAKA
1. DeCherney AH, Nathan L, & Goodwin TM. Spontaneous Abortion. Robertson A (editor). In:
Current Diagnosis and Treatment in Obstetric and Gynecology. New York: McGraw-Hill, 2003.
2. Hadijanto B. Perdarahan pada Kehamilan Muda. Saifuddin AB, Rachimhadhi T, Wiknjosastro
GH (editor), In: Ilmu Kebidanan, Edisi Keempat. Jakarta: PT Bina Pustaka Sarwono
Prawiroharjo, 2010.
3. Hanretty KP. Vaginal Bleeding in Pregnancy. Smith H (editor), In: Obstetrics Illustrated, 6th
Edition. London: Churchill-Livingstone, 2003.
4. World Health Organization. Managing incomplete abortion. WHO, 2008
5. Sharing responsibility: women, society and abortion worldwide. New York, The Allan
Guttmacher Institute,1999.
6. Christopher P. Crum. The Female Genital Tract. In: Ramzi S. Cotran, Vinay Kumar, Tucker
Collins. Pathologic Basis of Disease.7th ed. Philadelphia: WB. Saunders 2004; 1079-80.
7. Greenwold N, Jauniaux E. Collection of villous tissue under ultrasound guidance to improve the
cytogenetic study of early pregnancy failure. Hum Reprod 2002; 17: 45256.
8. Regan L, Rai R. Epidemiology and the medical causes of miscarriage. Baillieres Best Pract Res
Clin Obstet Gynaecol 2000; 14: 83954.
9. Basama FM, Crosfill F. The outcome of pregnancies in 182 women with threatened miscarriage.
Arch Gynecol Obstet 2004; 270:86-90
10. Weiss JL, Malone FD, Vidaver J, et al. Threatened abortion: A risk factor for poor pregnancy
outcome, a population-based screening study. Am J Obstet Gynecol 2004; 190:745-50.
11. Johns J, Jauniaux E. Threatened miscarriage as a predictor of obstetric outcome. Obstet Gynecol
2006; 107:845-50.
12. Tien JC & Tan TYT. Non surgical intervensions for threatened and recurrent miscarriages.
Singapore Med J, 2007; 48(12): 1074.
13. Backos, M and Regan, L. Recurrent Miscarriage. In: James, et al. (eds), High Risk Pregnancy
Management Options. 3rd Edition. Philadelphia: Elsevier Saunders, 2006; 160-182.
14. Pierce GB, Parchment RE, Lewellyn AL. Hydrogen peroxideas a mediator of programmed cell
death in the blastocyst. Differentiation 1991;46:181186.
15. Suganuma R, Yanagimachi R, Meistrich ML. Decline in fertility of mouse sperm with abnormal
chromatin during epididymal passage as revealed by ICSI. Hum Reprod 2005; 20: 3101-3108.
16. Caniggia I, Mostachfi H & Winter J. Hypoxia-inducible factor-1 mediates the biological effects
of oxygen on human trophoblast differentiation through TGF-beta. J Clin Invest 2000; 105: 577587.
17. Gupta S, Agarwal A, Banerjee J & Alvarez J. The role of oxidative stress in spontaneous
abortion and recurrent pregnancy loss: a systematic review. CME Review Article 2012; 62(5):
335-347.
18. Cohen RK & Koren G. Antioxidants and fetal protection against ethanol teratogenicity: review
of the experimental data and implications to humans. Neurotoxicol Teratol 2003; 25: 1-9.
19. Vural P, Akgul C, Yildirim A, et al. Antioxidant defence in recurrent abortion. Clin Chim Acta
2000; 295: 169-177.
20. Burd L, Roberts D, Odendaal H. ethanol and the placenta: a review. Journal of maternalfetal
and neonatal medicine 2007, 20(5):361375.
21. Weng X, Odouli R & Li DK. Maternal caffeine consumption during pregnancy and the risk of
miscarriage: a prospective cohort study. Am J Obstet Gynecol 2008; 198: 279-308.
22. Brent RL. Saving lives and changing family histories: Appropriate counseling of pregnant
women and men and women of reproductive age, concerning the risk of diagnostic radiation
exposures during and before pregnancy. Am J Obstet Gynecol, 2009, 200(1):4-24.
2

23. King H, Webb RT & Mortensen PB. Risk of stillbirth and neonatal death linked with maternal
mental illness: a national cohort study. archives of disease in childhood, fetal and neonatal, 2009
94(2): 105-110.
24. Fertl KI, Bergner A, Beyer R, Klapp BF & Rauchfuss BF. Levels and effects of different forms
of anxiety during pregnancy after a prior miscarriage. Eur. J. Obstet. Gynecol. Reprod. Biol.
2009; 142: 23-29.
25. Miozzo M & Simoni G. The role of imprinted genes in fetal growth. Biol Neonate 2002;81:217228.
26. Korevaar JC, Leschot NJ, Bossuyt PM, Knegt AC, Schoorl KB, Wouters CH, et al. Selective
chromosome analysis in couples with two or more miscarriages: casecontrol study. BMJ 2005;
331: 137-141.
27. Cunningham. Recurrent Miscarriage: Abortion. Mark E (editor), In: Williams Obstetrics 23 rd
Edition. New York: McGraw-Hil Companies, Inc. 2010.
28. Stirrat GM. Recurrent miscarriage I: definition and epidemiology. Lancet 1990; 336: 673-675
29. Godjin M. Chromosome abnormalities in first-trimester pregnancy loss. University of
Amsterdam, 2003; 1: 1-19.
30. Eiben B, Bartels I & Bahr-Porsch. Cytogenetic analysis of 50 spontaneous abortions with the
direct preparationn method of chorionic villi and its implications for studying genetic causes of
pregnancy wastage. American journal of Human Genetics 1990: 47; 656-663.
31. Dhont, Marc. Recurrent Miscarriage. Current Womens Health Reports 2003, 3: 361-366.
32. Robinson WP, McFadden DE & Stephenson MD. The origin of abnormalities in recurrent
aneuploidy/polyploidy. Am J Hum Genet. 2001; 69(6): 1245-1254.
33. Shi Q & Martin RH. Aneuploidy in human sperm: a review of the frequency and distribution of
aneuploidy, effects of donor age and lifestyle factors. Cytogenet Cell Genet 2000, 90:219-226.
34. Schweikert A, Rau T, Berkholz A, Allera A, Daufeldt S, Wildt L, et al. Association of
progesterone receptor polymorphism with recurrent abortions. Eur J Obstet Gynecol Reprod
Biol 2004: 113; 67-72.
35. Lebedev N, Nazarenko SA. Tissue-Specific Placental Mosaicism for Autosomal Trisomies in
Human Spontaneous Abortuses. Russian J of Genet 2001, 37(11):1224-1237.
36. Lee RM, Silver RM. Recurrent pregnancy loss: Summary and clinical recommendations. Semin
Reprod Med 2000, 18: 433-440.
37. Brosens JJ, Hodgetts A, Zaidi FF, Sherwin JR, Fusi L, Salker MS, et al. Proteomic analysis of
endometrium from fertile and infertile patients suggests a role for apolipoprotein A-I in embryo
implantation failure and endometriosis. Mol Hum Reprod 2010;16:273-285.
38. Teklenburg G, Salker M, Heijnen C, Macklon NS & Brosens JJ. The molecular basis of
recurrent pregnancy loss: impaired natural embryo selection. Mol Hum Reprod, 2010: 16(12):
886-895.
39. Suryanarayana V, Rao L, Kanakavalli M, Padmalatha V, Raseswari T, & Deenadayal M.
Association between novel HLA-G genotypes and risk of recurrent miscarriages: A case-control
study in a South Indian population. Repro Sci, 2008; 15: 817-824.
40. Rossant. Placental development: lessons from mouse mutants. Nat Rev Genet, 2001; 2(7): 538548.
41. Choi HK, Choi BC, Lee SH, Kim JW, Cha KY & Baek KH. Expression of angiogenesis and
apoptosisrelated genes in chorionic villi derived from recurrent pregnancy patients. Mol
Reprod Dev, 2003; 66:24-33.
42. Laird SM, Tuckerman EM, Cork BA, Linjawi S, Blakemore AF, Li TC, et al. A review of
immune cells and molecules in women with recurrent miscarriage. Human Reproduction
Update 2003: 9(2); 163-174.
43. Salmon JE. A noninflammatory pathway for pregnancy loss:innate immune activation.
44. Novak RF. A Brief Review of Anatomy, Histology and ultrastructure of the full term placenta.
Archives of Pathology & Laboratory Medicine 1991;115: 654-659.
3

45. Haque AU, Siddique S, Jafari M, Hussain I & Siddiqui S. Pathology of chorionic villi in
spontaneous abortions. International Journal of Pathology 2004; 2(1): 5-9
46. Emmrich P. Pathology of the placenta. Zentralbl Pathol 1992; 138: 1-8.
47. Ladefoged C. A histopathological investigation of 260 early abortions. Acta Obstet Gynecol
Scand 1980; 59: 509-512.
48. Salim R, Regan L, Woelfer B, Backos M & Jurkovic D. A comparative study of the morphology
of congenital uterine anomalies in women with and without a history of recurrent first trimester
miscarriage. Hum. Reprod. 2003: 18; 162-166.
49. Dhont, Marc. Recurrent Miscarriage. Current Womens Health Reports 2003, 3:361366.
Current Science Inc. ISSN 15345874 Copyright 2003 by Current Science Inc
50. Prawirohardjo,S. Abortus. Ilmu Kebidanan. Edisi Ketiga. Jakarta: Yayasan Bina Pustaka
Sarwono Prawirohardjo. 2006. Hal.302-304; 309-310
51. Brenner, B., 2004. Haemostatic changes in pregnancy. Thromb. Res. 114, 409414
52. Roberts, D., Schwartz, R.S., 2002. Clotting and hemorrhage in the placentaa delicate balance.
N. Engl. J. Med. 347, 5759
53. Rai, R., Tuddenham, E., Backos, M., Jivraj, S., Elgaddal, S., Choy, S., Cork, B., Regan, L.,
2003. Thromboelastography, whole-blood haemostasis and recurrent miscarriage. Hum. Reprod.
18, 25402543.
54. Jeschke, U., Richter, D.U., Walzel, H., Bergemann, C., Mylonas, I., Sharma, S., Keil, C., Briese,
V., Friese, K., 2003a. Stimulation of hCG and inhibition of hPL in isolated human trophoblast
cells in vitro by glycodelin A. Arch. Gynecol. Obstet. 268, 162167.
55. Toth B, Bastug M, Scholz C, Arck P, Schulze S & Kunze S, et al. Leptin and peroxisome
proliferator-activatedreceptors: impact on normal and disturbed first trimester human pregnancy.
Histol. Histopathol., 2008; 23:1465-1475.
56. Gardiner C, Cohen S, Austin S, Machin SJ, & Mackie IJ. Pregnancy loss, tissue factor pathway
inhibitor deficiency, and resistance to activated protein C. J Thromb Haemost 2006; 4: 27242726.
57. Lappas M, Permezel M & Rice GE. Leptin and adiponectin stimulatethe release of
proinflammatory cytokines and prostaglandinsfrom human placenta and maternal adipose tissue
via nuclear factorkappaB,peroxisomal proliferator-activated receptor-gamma andextracellularly
regulated kinase 1/2. Endocrinology, 2005; 146: 3334-3342.
58. Hiby SE, Regan L, Lo W, Farrell L, Carrington M & Moffett A. Association of maternal killercell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage.
Hum. Reprod., 2008; 23; 972-976.
59. Expression of Ki-67, Bcl-2 and Bax in the First Trimester Abortion Materials.
60. Kokawa K, Shikone T, Nakano R: Apoptosis in human chorionic villi and decidua during
normal embryonic development and spontaneous abortion in the first trimester. Placenta 1998,
19:21-26
61. Lea RG, Al-Sharekh N, Tulppala M, Critchley HOD: The immunolocalization of Bcl-2 at the
maternal-fetal interface in healthy and failing pregnancies. Hum Reprod 1997, 12:153-158.
62. foley_ch18_p213-222.pdf
63. Ikossi DG, Lazar AA, Morabito D, Fildes J, & Knudson MM. Profile of mothers at risk: an
analysis of injury and pregnancy loss in 1195 trauma patients. J Am oll Surg, 2004; 9(16): 4956.
64. Connor JP, Brudney A, Ferrer K & Fazleabas AT.GlycodelinA expression in the uterine
cervix. Gynecol Oncol., 2000; 79: 216219.
65. Eblen AC, GercelTaylor C, Shields LBE, Sanfilippo JS, Nakajima ST & Taylor DD.
Alterations in humoral immune responses associated with recurrent pregnancy loss. Fertil
Steril 2000; 73;305313.
66. Segal-Lieberman G, Karasik A, Shimon I. Hypopituitarism following closed head injury.
Pituitary 2000;3:181184
67. Kelly DF, Gonzalo IT, Cohan P, et al. Hypopituitarism following traumatic brain injury and
aneurysmal subarachnoid hemorrhage: a preliminary report. J Neurosurg 2000;93:743752
4

68. Weiss HB, Songer TJ, Fabio A. Fetal deaths related to maternal injury. JAMA 2001;286:1863
1868..
69. Mochtar, Rustam., S., Amru. 2012. Abortus. Dalam: Sinopsis Obstetri (Obstetri Fisiologi &
Obstetri Patologi). Jakarta: Penerbit Buku Kedokteran EGC.
70. Toth B, Jeschke U, Rogenhofer N, Scholz C, Wufel W, Thaler CJ, et al. Recurrent miscarriage:
current concepts in diagnosis and treatment. Journal of Reproductive Immunology 2010; 12(6):
1-8.
71. Dolitzky, M., Inbal, A., Segal, Y., Weiss, A., Brenner, B., Carp, H., 2006. A randomized study of
thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertil.
Steril. 86, 362366.
72. Norwitz, E.R., Schorge, J.O, 2008. At a Glance Obstetri dan Ginekologi. Jakarta: Penerbit
Erlangga; Sastrawinata, S., Martaadisoebrata, D., Wirakusumah, F.F., 2005. Ilmu Kesehatan
Reproduksi: Obstetri Patologi. Ed. 2. Jakarta : EGC
73. Evans & Arthur T. Manual of Obstetric 7th. Lippincott Williams and Wilkins. 2007.
74. NICE. Ectopic pregnancy and miscarriage. NICE, 2012; 154: 1-38.
75. POGI. Standar Pelayanan Medik. POGI, 2006.
76. Meka A & Reddy BM. Recurrent spontaneous abortions: an overview of genetic and non gentic
background.
77. The Impact of Dydrogesterone Supplementation on Hormonal Profile and Progesterone-induced
Blocking Factor Concentrations in Women with Threatened.
78. El-Zibdeh MY. Dydrogesterone in the reduction of recurrent spontaneous abortion. J Steroid
Biochem Mol Biol 2005; 97:431-4
79. Omar MH, Mashita MK, Lim PS, Jamil MA. Dydrogesterone in threatened abortion: pregnancy
outcome. J Steroid Biochem Mol Biol 2005; 97:421-5
80. Yost NP, Owen J, Berghella V, et al. Effect of coitus on recurrent preterm birth. Obstet Gynecol
2006; 107:793-7
81. Rumbold A, Middleton P, Crowther CA. Vitamin supplementation for preventing miscarriage.
Cochrane Database Syst Rev 2005; CD004073
82. Qureshi NS, Edi-Osagie EC, Ogbo V, Ray S, Hopkins RE. First trimester threatened miscarriage
treatment with human chorionic gonadotrophins: a randomised controlled trial. BJOG 2005;
112:1536-41.
83. Bui Q. Management Options for Early Incomplete Miscarriage. University of California.
84. Sur SD, Raine-Fenning NJ. The management of miscarriage. Best Pract Res Clin Obstet
Gynaecol. 2009;23(4):479-491.
85. Reynolds A, Ayres-de-Campos D, Costa MA & Montenegro N. How should success be defined
when attempting medical resolution of first-trimester missed abortion?. Eur J Obstet Gynecol
Reprod Biol 2005;118:716
86. Wood SL, Brain PH. Medical management of missed abortion: a randomised controlled trial.
Obstet Gynecol 2002;99:5636..
87. Fawcus S, McIntyre J, Jewkes RK, Rees H, Katzenellenbogen JM,Shabodien R, et al.
Management of incomplete abortions at South African public hospitals. National Incomplete
Abortion Study Reference Group. S Afr Med J 1997;1(4):438442
88. Chow AW, Marshall, JR, Guze LB. A double-blind comparison ofclindamycin with penicillin
plus chloramphenicol in treatment of septic abortion. J Infect Dis 1977;135(Suppl):S3539
89. Seeras R, Evaluation of prophylactic use of tetracycline after evacuation in abortion in Harare
Central Hospital. Seeras R , Evaluation of prophylactic use of tetracycline after evacuation in
abortion inHarare Central Hospital. East Afr Med J 1989;66(9):60710..
90. Zhang J, Giles JM, Barnhart K, Creinin MD,Westhoff C, Frederick MM. A comparison of
medical management with misoprostol and surgical management for early pregnancy failure. N
Engl J Med 2005;353:7619..
91. Gulmezoglu MW & Thike BK. Antibiotics for incomplete abortion. Cochrane, 2012; 1: 1-10.
92. Heath V, Chadwick V, Cooke I, Manek S & MacKenzie IZ. Should tissue from pregnancy
termination and uterine evacuation routinely be examined histologically?. BJOG 2000;107:727
30
5

93. Misoprostol for treatment for incomplete abortion


94. Tang OS, Lau WNT, Ng EHY, Lee SWH, & Ho PC. A prospective randomized study to
compare the use of repeated doses of vaginal with sublingual misoprostol in the management of
first trimester silent miscarriages. Hum Reprod 2003;18:17681;
95. IGO_incomp_Blum.pdf chung et al
96. Sagili H & Divers M. Review modern management of miscarriage. RCOG 2007; 9: 102-108.
97. Ngoc NT, Blum J,Westheimer E, Quan TT,Winikoff B. Medical treatment of missed abortion
using misoprostol. Int J Gynecol Obstet 2004;87:13842
98. Meka A & Reddy BM. Recurrent spontaneous abortion: an overview of genetic and non gentic
background.
99. Corrado F, Dugo C, Cannata M, Di Bartolo M, Scilipoti A & Stella N. A randomised trial of
progesterone prophylaxis aftermidtrimester amniocentesis. European Journal of Obstetrics &
Gynecology and Reproductive Biology 2002; 100(2): 196-8.
100. Wiebe et al. Reducing surgery in management of spontaneous abortions. Can Fam Physician,
1999: 45: 1-10.
101. Hure AJ, Powers JR & Loxton D. Misarriage, preterm delivery, dan stillbirth. PLoS One,
2012; 7(5): 1-9.
102. World Health Organization. Managing incomplete abortion. WHO, 2008.
103. Pernoll ML. Habitual Abortion. Dalam: Benson and Pernolls Handbook of Obstetrics and
Gynecology. New York: McGraw-Hill Companies, 2001.
104. Tien JC & Tan TYT. Non-surgical Interventions for Threatened and Recurrent Miscarriages.
Singapore Med J 2007; 48(12): 1074-1081.